Skip to content

Clinical trials

Thyroid Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20082
20111
20121
20154
20174
20181
20191
20201
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting7
Recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.3
Eli Lilly and Company3
Exelixis2
Genzyme, a Sanofi Company2
National Cancer Institute (NCI)2
Pfizer2
Actym Therapeutics, Inc.1
Apollomics Inc.1
Bayer1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms23
Carcinoma, Non-Small-Cell Lung10
Breast Neoplasms7
Melanoma7
Carcinoma, Medullary6
Colonic Neoplasms6
Lung Neoplasms5
Neoplasms5
Sarcoma5
Colorectal Neoplasms4

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.